{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11678659", "DateCompleted": {"Year": "2001", "Month": "12", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "02", "Day": "23"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0163-3864", "JournalIssue": {"Volume": "64", "Issue": "10", "PubDate": {"Year": "2001", "Month": "Oct"}}, "Title": "Journal of natural products", "ISOAbbreviation": "J Nat Prod"}, "ArticleTitle": "Antimalarial (+)-trans-hexahydrodibenzopyran derivatives from Machaerium multiflorum.", "Pagination": {"StartPage": "1322", "EndPage": "1325", "MedlinePgn": "1322-5"}, "Abstract": {"AbstractText": ["Bioassay-guided fractionation of Machaerium multiflorum yielded the hitherto unreported (+)-trans-hexahydrodibenzopyrans machaeriol A (1) and machaeriol B (2), as well as the known guaiane sesquiterpene (-)-kessane. Structure elucidation was based on (1)H and (13)C NMR data, mainly 2D NMR (1)H-(1)H COSY, (1)H-(13)C HMQC, (1)H-(13)C HMBC, and (1)H-(1)H NOESY experiments. This is the first report of the hexahydrodibenzopyrans from a higher plant other than the genus Cannabis. The cannabimimetic activity was thus evaluated by radioligand binding assay for cannabinoid receptor CB1, which indicated, notably, that both 1 and 2 were inactive. In addition, the cross reactivity of 1 and 2 toward antibodies designed for urinary metabolites of cannabinoids was evaluated with the EMIT and On Line cannabinoids assays. Both compounds showed no response at 100 000 ng/mL in both assays. Machaeriol B (2) demonstrated in vitro antimalarial activity (IC(50) = 120 ng/mL) against Plasmodium falciparum W-2 clone."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "National Center for Natural Products Research, Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, USA. milias@sunset.backbone.olemiss.edu"}], "Identifier": [], "LastName": "Muhammad", "ForeName": "I", "Initials": "I"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Li", "ForeName": "X C", "Initials": "XC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dunbar", "ForeName": "D C", "Initials": "DC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "ElSohly", "ForeName": "M A", "Initials": "MA"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khan", "ForeName": "I A", "Initials": "IA"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Nat Prod", "NlmUniqueID": "7906882", "ISSNLinking": "0163-3864"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antimalarials"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzopyrans"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzoxazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Cannabinoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Morpholines"}, {"RegistryNumber": "0", "NameOfSubstance": "Naphthalenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "kessane"}, {"RegistryNumber": "0", "NameOfSubstance": "machaeriol A"}, {"RegistryNumber": "0", "NameOfSubstance": "machaeriol B"}, {"RegistryNumber": "5H31GI9502", "NameOfSubstance": "(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone"}, {"RegistryNumber": "7XU7A7DROE", "NameOfSubstance": "Amphotericin B"}, {"RegistryNumber": "886U3H6UFF", "NameOfSubstance": "Chloroquine"}, {"RegistryNumber": "F8VB5M810T", "NameOfSubstance": "Tetracycline"}, {"RegistryNumber": "Q91FH1328A", "NameOfSubstance": "Methicillin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Amphotericin B"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Antimalarials"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Benzopyrans"}, {"QualifierName": [], "DescriptorName": "Benzoxazines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cannabinoids"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chloroquine"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cryptococcus neoformans"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Microbial"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fabaceae"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Magnetic Resonance Spectroscopy"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Methicillin"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Morpholines"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Naphthalenes"}, {"QualifierName": [], "DescriptorName": "Peru"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Stems"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Plasmodium falciparum"}, {"QualifierName": ["chemistry", "isolation & purification", "pharmacology"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Infrared"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Ultraviolet"}, {"QualifierName": [], "DescriptorName": "Spectroscopy, Fourier Transform Infrared"}, {"QualifierName": ["drug effects"], "DescriptorName": "Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetracycline"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "10", "Day": "27", "Hour": "10", "Minute": "0"}, {"Year": "2002", "Month": "1", "Day": "5", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "10", "Day": "27", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11678659", "10.1021/np0102861", "np0102861"]}}], "PubmedBookArticle": []}